Abcellera Biologics Inc (ABCL) Event June 21, 2022, 16:28 UTC 16 1 comments (50% Neutral) ABCELLERA BIOLOGICS INC. (ABCL) Announces Regulatory Update Comment Full text
Generation Bio (GBIO) Event June 21, 2022, 12:36 UTC 16 1 comments (99% Positive) Generation Bio Co. (GBIO) Announces Clinical Development Update Comment Full text
Genmab (GMAB) Event June 21, 2022, 12:33 UTC 15 1 comments (99% Neutral) Genmab (GMAB) Announces Clinical Development Update (Form 6-K) Comment Full text
Immunic Inc (IMUX) Event June 21, 2022, 12:31 UTC 16 1 comments (99% Neutral) IMMUNIC, INC. (IMUX) Files Form 8-K Comment Full text
PTC Therapeutics Inc (PTCT) Event June 21, 2022, 12:15 UTC 16 1 comments (19% Negative) PTC THERAPEUTICS, INC. (PTCT) Files Form 8-K Comment Full text
Recursion Pharmaceuticals Inc (RXRX) Event June 21, 2022, 12:04 UTC 16 1 comments (80% Positive) RECURSION PHARMACEUTICALS, INC. (RXRX) Announces Enrollment Update for designations Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment Comment Full text
Prelude Therapeutics (PRLD) Event June 21, 2022, 12:00 UTC 16 1 comments (99% Neutral) Prelude Therapeutics Inc (PRLD) Files Form 8-K Comment Full text
Tonix Pharmaceuticals Holding Corp (TNXP) Event June 21, 2022, 11:06 UTC 15 1 comments (99% Neutral) TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Announces Clinical Development Update Comment Full text
Karuna Therapeutics (was acquised by Bristol Myers Squibb (NYSE: BMY) on 18/03/2024) (KRTX) Event June 21, 2022, 11:06 UTC 16 1 comments (99% Neutral) KARUNA THERAPEUTICS, INC. (KRTX) Announces Regulatory Update Comment Full text
Xenon Pharmaceuticals Inc (XENE) Event June 21, 2022, 11:03 UTC 16 1 comments (10% Negative) XENON PHARMACEUTICALS INC. (XENE) Announces Delay in patients Development Timeline Due to Geopolitical Situation, Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment Comment Full text